Apellis Pharmaceuticals to Present at the 2020 Evercore ISI HealthCONx Conference

Rhea-AI Summary

Apellis Pharmaceuticals (Nasdaq: APLS) announced its participation in the 2020 Evercore ISI HealthCONx Conference on December 3, 2020 at 1:25 p.m. ET. The event will feature a fireside chat with Cedric Francois, M.D., Ph.D., co-founder and CEO. Interested parties can access the live webcast via the company's Investors and Media section. A replay will be available for 90 days afterwards. Apellis specializes in targeted C3 therapies for debilitating diseases such as those in hematology, ophthalmology, nephrology, and neurology.

WALTHAM, Mass., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that the company will present at the 2020 Evercore ISI HealthCONx Conference on Thursday, December 3, 2020 at 1:25 p.m. ET. The conference will be held in a virtual meeting format.

Cedric Francois, M.D., Ph.D., co-founder and chief executive officer of Apellis, will participate in a fireside chat. The event will be available live via webcast from the “Events and Presentations” page of the “Investors and Media” section of the company’s website at https://investors.apellis.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Apellis
Apellis Pharmaceuticals, Inc. is a global biopharmaceutical company that is committed to leveraging courageous science, creativity, and compassion to deliver life-changing therapies. Leaders in targeted C3 therapies, we aim to develop transformative therapies for a broad range of debilitating diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, nephrology, and neurology. For more information, please visit www.apellis.com.

Investor Contact:
Argot Partners
apellis@argotpartners.com
+1 212.600.1902

FAQ

What date will Apellis Pharmaceuticals present at the Evercore ISI HealthCONx Conference?

Apellis Pharmaceuticals will present on December 3, 2020.

Who is participating in the fireside chat at the Evercore ISI HealthCONx Conference?

Cedric Francois, M.D., Ph.D., co-founder and CEO of Apellis Pharmaceuticals, will participate.

How can I watch the Apellis Pharmaceuticals presentation at the conference?

The presentation will be available live via webcast on the Investors and Media section of Apellis' website.

Is there a replay available for the Apellis Pharmaceuticals conference presentation?

Yes, a replay of the presentation will be available for 90 days after the event.

What is the focus of Apellis Pharmaceuticals?

Apellis focuses on developing targeted C3 therapies for conditions affected by the complement cascade.